Pharmacokinetics of intravenous ATP in cancer patients.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 49, doi. 10.1007/s002280050719
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2000 AND VI 56 AND IP 1
Results: 15
1
2
Nilvadipine protects low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 35, doi. 10.1007/s002280050717
- By:
- Publication type:
- Article
3
Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 89, doi. 10.1007/s002280050726
- By:
- Publication type:
- Article
4
Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 75
- By:
- Publication type:
- Article
5
Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adults.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 69, doi. 10.1007/s002280050723
- By:
- Publication type:
- Article
6
Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 43, doi. 10.1007/s002280050718
- By:
- Publication type:
- Article
7
Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 61, doi. 10.1007/s002280050721
- By:
- Publication type:
- Article
8
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 1, doi. 10.1007/s002280050714
- By:
- Publication type:
- Article
9
Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9<sup>*</sup>3 allele.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 65, doi. 10.1007/s002280050722
- By:
- Publication type:
- Article
10
Workplace drug testing (WDT) likely to increase in Europe : Report from the First European Symposium on WDT including selected abstracts.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 103
- By:
- Publication type:
- Article
11
The use of fixed-mixture insulins in clinical practice.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 19, doi. 10.1007/s002280050715
- By:
- Publication type:
- Article
12
Antibiotic utilization at the university hospital after introducing an antibiotic policy.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 97, doi. 10.1007/s002280050727
- By:
- Publication type:
- Article
13
Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 81, doi. 10.1007/s002280050725
- By:
- Publication type:
- Article
14
The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 57, doi. 10.1007/s002280050720
- By:
- Publication type:
- Article
15
Evidence of clinical efficacy of homeopathy : A meta-analysis of clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2000, v. 56, n. 1, p. 27, doi. 10.1007/s002280050716
- By:
- Publication type:
- Article